Financhill
Sell
19

IRIX Quote, Financials, Valuation and Earnings

Last price:
$1.00
Seasonality move :
-9.55%
Day range:
$0.94 - $0.95
52-week range:
$0.78 - $2.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.32x
P/B ratio:
18.68x
Volume:
144.1K
Avg. volume:
83K
1-year change:
-61.62%
Market cap:
$15.9M
Revenue:
$48.7M
EPS (TTM):
-$0.43

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
IRIX
IRIDEX
$12.8M -$0.12 -2.72% -18.18% --
AXGN
Axogen
$48.3M $0.02 10.96% -76% $24.43
ELMD
Electromed
$15.8M -- 12.26% -- $37.00
MODD
Modular Medical
-- -$0.12 -- -47.83% $8.00
MYO
Myomo
$9.2M -$0.08 21.89% -258.33% $9.05
STXS
Stereotaxis
$6.9M -$0.07 72.15% -3.57% $4.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
IRIX
IRIDEX
$0.95 -- $15.9M -- $0.00 0% 0.32x
AXGN
Axogen
$10.96 $24.43 $499.2M -- $0.00 0% 2.52x
ELMD
Electromed
$20.33 $37.00 $170.5M 25.73x $0.00 0% 2.97x
MODD
Modular Medical
$0.87 $8.00 $35.5M -- $0.00 0% --
MYO
Myomo
$3.07 $9.05 $110.5M -- $0.00 0% 3.09x
STXS
Stereotaxis
$2.10 $4.50 $180.6M -- $0.00 0% 6.58x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
IRIX
IRIDEX
81.05% 1.797 21.92% 1.11x
AXGN
Axogen
31.17% 1.036 5.67% 2.22x
ELMD
Electromed
-- 2.545 -- 4.79x
MODD
Modular Medical
-- -0.806 -- --
MYO
Myomo
-- 2.360 -- 2.24x
STXS
Stereotaxis
-- 1.450 -- 0.62x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
IRIX
IRIDEX
$5.1M -$205K -140.14% -218.69% -1.72% -$1.2M
AXGN
Axogen
$34.9M -$1.7M -4.88% -7.2% -3.26% -$13.8M
ELMD
Electromed
$12.2M $2.1M 16.57% 16.57% 13.65% $2.2M
MODD
Modular Medical
-- -$4.9M -- -- -- -$4.6M
MYO
Myomo
$6.6M -$3.5M -38.11% -38.11% -35.81% -$3.3M
STXS
Stereotaxis
$4.1M -$5.9M -174.6% -174.6% -79.35% -$1.8M

IRIDEX vs. Competitors

  • Which has Higher Returns IRIX or AXGN?

    Axogen has a net margin of -14.17% compared to IRIDEX's net margin of -7.9%. IRIDEX's return on equity of -218.69% beat Axogen's return on equity of -7.2%.

    Company Gross Margin Earnings Per Share Invested Capital
    IRIX
    IRIDEX
    42.49% -$0.10 $4.5M
    AXGN
    Axogen
    71.94% -$0.08 $153.1M
  • What do Analysts Say About IRIX or AXGN?

    IRIDEX has a consensus price target of --, signalling upside risk potential of 110.97%. On the other hand Axogen has an analysts' consensus of $24.43 which suggests that it could grow by 122.89%. Given that Axogen has higher upside potential than IRIDEX, analysts believe Axogen is more attractive than IRIDEX.

    Company Buy Ratings Hold Ratings Sell Ratings
    IRIX
    IRIDEX
    0 0 0
    AXGN
    Axogen
    5 0 0
  • Is IRIX or AXGN More Risky?

    IRIDEX has a beta of 0.692, which suggesting that the stock is 30.819% less volatile than S&P 500. In comparison Axogen has a beta of 1.195, suggesting its more volatile than the S&P 500 by 19.457%.

  • Which is a Better Dividend Stock IRIX or AXGN?

    IRIDEX has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Axogen offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IRIDEX pays -- of its earnings as a dividend. Axogen pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IRIX or AXGN?

    IRIDEX quarterly revenues are $11.9M, which are smaller than Axogen quarterly revenues of $48.6M. IRIDEX's net income of -$1.7M is higher than Axogen's net income of -$3.8M. Notably, IRIDEX's price-to-earnings ratio is -- while Axogen's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IRIDEX is 0.32x versus 2.52x for Axogen. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IRIX
    IRIDEX
    0.32x -- $11.9M -$1.7M
    AXGN
    Axogen
    2.52x -- $48.6M -$3.8M
  • Which has Higher Returns IRIX or ELMD?

    Electromed has a net margin of -14.17% compared to IRIDEX's net margin of 12.06%. IRIDEX's return on equity of -218.69% beat Electromed's return on equity of 16.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    IRIX
    IRIDEX
    42.49% -$0.10 $4.5M
    ELMD
    Electromed
    77.97% $0.21 $43.9M
  • What do Analysts Say About IRIX or ELMD?

    IRIDEX has a consensus price target of --, signalling upside risk potential of 110.97%. On the other hand Electromed has an analysts' consensus of $37.00 which suggests that it could grow by 82%. Given that IRIDEX has higher upside potential than Electromed, analysts believe IRIDEX is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    IRIX
    IRIDEX
    0 0 0
    ELMD
    Electromed
    2 0 0
  • Is IRIX or ELMD More Risky?

    IRIDEX has a beta of 0.692, which suggesting that the stock is 30.819% less volatile than S&P 500. In comparison Electromed has a beta of 0.460, suggesting its less volatile than the S&P 500 by 53.993%.

  • Which is a Better Dividend Stock IRIX or ELMD?

    IRIDEX has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IRIDEX pays -- of its earnings as a dividend. Electromed pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IRIX or ELMD?

    IRIDEX quarterly revenues are $11.9M, which are smaller than Electromed quarterly revenues of $15.7M. IRIDEX's net income of -$1.7M is lower than Electromed's net income of $1.9M. Notably, IRIDEX's price-to-earnings ratio is -- while Electromed's PE ratio is 25.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IRIDEX is 0.32x versus 2.97x for Electromed. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IRIX
    IRIDEX
    0.32x -- $11.9M -$1.7M
    ELMD
    Electromed
    2.97x 25.73x $15.7M $1.9M
  • Which has Higher Returns IRIX or MODD?

    Modular Medical has a net margin of -14.17% compared to IRIDEX's net margin of --. IRIDEX's return on equity of -218.69% beat Modular Medical's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IRIX
    IRIDEX
    42.49% -$0.10 $4.5M
    MODD
    Modular Medical
    -- -$0.13 --
  • What do Analysts Say About IRIX or MODD?

    IRIDEX has a consensus price target of --, signalling upside risk potential of 110.97%. On the other hand Modular Medical has an analysts' consensus of $8.00 which suggests that it could grow by 817.12%. Given that Modular Medical has higher upside potential than IRIDEX, analysts believe Modular Medical is more attractive than IRIDEX.

    Company Buy Ratings Hold Ratings Sell Ratings
    IRIX
    IRIDEX
    0 0 0
    MODD
    Modular Medical
    1 0 0
  • Is IRIX or MODD More Risky?

    IRIDEX has a beta of 0.692, which suggesting that the stock is 30.819% less volatile than S&P 500. In comparison Modular Medical has a beta of -4.845, suggesting its less volatile than the S&P 500 by 584.542%.

  • Which is a Better Dividend Stock IRIX or MODD?

    IRIDEX has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Modular Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IRIDEX pays -- of its earnings as a dividend. Modular Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IRIX or MODD?

    IRIDEX quarterly revenues are $11.9M, which are larger than Modular Medical quarterly revenues of --. IRIDEX's net income of -$1.7M is higher than Modular Medical's net income of -$4.8M. Notably, IRIDEX's price-to-earnings ratio is -- while Modular Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IRIDEX is 0.32x versus -- for Modular Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IRIX
    IRIDEX
    0.32x -- $11.9M -$1.7M
    MODD
    Modular Medical
    -- -- -- -$4.8M
  • Which has Higher Returns IRIX or MYO?

    Myomo has a net margin of -14.17% compared to IRIDEX's net margin of -35.24%. IRIDEX's return on equity of -218.69% beat Myomo's return on equity of -38.11%.

    Company Gross Margin Earnings Per Share Invested Capital
    IRIX
    IRIDEX
    42.49% -$0.10 $4.5M
    MYO
    Myomo
    67.23% -$0.08 $21.7M
  • What do Analysts Say About IRIX or MYO?

    IRIDEX has a consensus price target of --, signalling upside risk potential of 110.97%. On the other hand Myomo has an analysts' consensus of $9.05 which suggests that it could grow by 194.79%. Given that Myomo has higher upside potential than IRIDEX, analysts believe Myomo is more attractive than IRIDEX.

    Company Buy Ratings Hold Ratings Sell Ratings
    IRIX
    IRIDEX
    0 0 0
    MYO
    Myomo
    3 0 0
  • Is IRIX or MYO More Risky?

    IRIDEX has a beta of 0.692, which suggesting that the stock is 30.819% less volatile than S&P 500. In comparison Myomo has a beta of 1.633, suggesting its more volatile than the S&P 500 by 63.336%.

  • Which is a Better Dividend Stock IRIX or MYO?

    IRIDEX has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IRIDEX pays -- of its earnings as a dividend. Myomo pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IRIX or MYO?

    IRIDEX quarterly revenues are $11.9M, which are larger than Myomo quarterly revenues of $9.8M. IRIDEX's net income of -$1.7M is higher than Myomo's net income of -$3.5M. Notably, IRIDEX's price-to-earnings ratio is -- while Myomo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IRIDEX is 0.32x versus 3.09x for Myomo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IRIX
    IRIDEX
    0.32x -- $11.9M -$1.7M
    MYO
    Myomo
    3.09x -- $9.8M -$3.5M
  • Which has Higher Returns IRIX or STXS?

    Stereotaxis has a net margin of -14.17% compared to IRIDEX's net margin of -77.93%. IRIDEX's return on equity of -218.69% beat Stereotaxis's return on equity of -174.6%.

    Company Gross Margin Earnings Per Share Invested Capital
    IRIX
    IRIDEX
    42.49% -$0.10 $4.5M
    STXS
    Stereotaxis
    54.39% -$0.07 $8.2M
  • What do Analysts Say About IRIX or STXS?

    IRIDEX has a consensus price target of --, signalling upside risk potential of 110.97%. On the other hand Stereotaxis has an analysts' consensus of $4.50 which suggests that it could grow by 114.29%. Given that Stereotaxis has higher upside potential than IRIDEX, analysts believe Stereotaxis is more attractive than IRIDEX.

    Company Buy Ratings Hold Ratings Sell Ratings
    IRIX
    IRIDEX
    0 0 0
    STXS
    Stereotaxis
    2 0 0
  • Is IRIX or STXS More Risky?

    IRIDEX has a beta of 0.692, which suggesting that the stock is 30.819% less volatile than S&P 500. In comparison Stereotaxis has a beta of 1.461, suggesting its more volatile than the S&P 500 by 46.088%.

  • Which is a Better Dividend Stock IRIX or STXS?

    IRIDEX has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IRIDEX pays -- of its earnings as a dividend. Stereotaxis pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IRIX or STXS?

    IRIDEX quarterly revenues are $11.9M, which are larger than Stereotaxis quarterly revenues of $7.5M. IRIDEX's net income of -$1.7M is higher than Stereotaxis's net income of -$5.8M. Notably, IRIDEX's price-to-earnings ratio is -- while Stereotaxis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IRIDEX is 0.32x versus 6.58x for Stereotaxis. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IRIX
    IRIDEX
    0.32x -- $11.9M -$1.7M
    STXS
    Stereotaxis
    6.58x -- $7.5M -$5.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth
Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth

Microsoft (NASDAQ:MSFT) has been among the top growth stocks of…

Is Tesla Stock Overvalued or a Buy for the Next Decade?
Is Tesla Stock Overvalued or a Buy for the Next Decade?

Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…

Is Apple Stock Undervalued or Overvalued?
Is Apple Stock Undervalued or Overvalued?

For many years, Apple (NASDAQ:AAPL) was just about the perfect…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
68
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
10
EXOD alert for May 29

Exodus Movement [EXOD] is up 15.65% over the past day.

Buy
80
SBET alert for May 29

SharpLink Gaming [SBET] is up 170.92% over the past day.

Buy
100
BOX alert for May 29

Box [BOX] is up 0.27% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock